AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12679312
Drug: Dextromethorphan 90
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 90 mg thrice daily
Trial: 12679312
Drug: Dextromethorphan 120
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 120 to 270 mg/day
Trial: 9013088
Drug: E2/NETA (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/NETA (continuous oral 17 beta‐oestradiol 2 mg day‐1 and norethisterone acetate 1 mg day‐1)
Trial: 9013088
Drug: E2/MPA (transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/MPA (transdermal 17 beta‐oestradiol 50 micrograms day‐1 with oral cyclic medroxyprogesterone acetate 10 mg day‐1 on days 17-28)
Trial: 1524955
Drug: Bestatin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bestatin (30 mg orally daily for three months after molar deliveries)
Trial: 1524955
Drug: Bestatin non-administered
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bestatin non-administered group
Trial: 21234550
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (NIC)
Trial: 23689969
Drug: Neydharting mud-pack
RxNorm normalized name: aminophylline / ephedrine hydrochloride / guaifenesin / phenobarbital Oral Tablet [Mudrane GG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neydharting mud-pack therapy
Trial: 18201563
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg pravastatin/day
Trial: 8554936
Drug: (S)-flurbiprofen (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-flurbiprofen (50 mg)
Trial: 8554936
Drug: (R)-flurbiprofen (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R)-flurbiprofen (50 mg)
Trial: 8554936
Drug: (R)-flurbiprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R)-flurbiprofen (100 mg)
Trial: 2111665
Drug: Heparin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin therapy (5,000 IU)
Trial: 31092252
Drug: Elements virtual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elements virtual rehabilitation (three weekly 30-40 min sessions for four weeks) combined with treatment as usual
Trial: 23392747
Drug: HCl (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCl (0.1 N) infusion
Trial: 11098966
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition enriched with arginine and glutamate (GlnP+ group)
Trial: 11098966
Drug: Conventional total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional total parenteral nutrition (control group)
Trial: 9203170
Drug: Citicoline 1000
RxNorm normalized name: citicoline 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline 1000 mg/day
Trial: 9203170
Drug: Citicoline 500
RxNorm normalized name: citicoline 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline 500 mg/day
Trial: 9203170
Drug: Citicoline 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline 300 mg/day + Nimodipine 90 mg/day
Trial: 8315428
Drug: PCNU 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCNU 100 mg/m2 every 7 weeks for 1 year and every 10 weeks for the second year
Trial: 8315428
Drug: BCNU 200
RxNorm normalized name: Carmustine
DrugBank: Carmustine (DB00262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BCNU 200 mg/m2 every 7 weeks for 1 year and every 10 weeks for the second year
Trial: 29361312
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia (IV) with fentanyl, metamizole, dexketoprofen, ondansetron, and postoperative perfusion of metamizole 4%, tramadol 0.2%, ondansetron 0.08% 2ml·h‐1; PCA bolus 2mL/20min for 24 hours
Trial: 27219522
Drug: DE‐EBRT with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DE‐EBRT with bicalutamide 150 mg once daily for 5 months
Trial: 27219522
Drug: DE‐EBRT without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DE‐EBRT without hormone therapy
Trial: 27219522
Drug: Dose escalation
RxNorm normalized name: PALFORZIA Initial Dose Escalation KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose escalation to >75.6 Gy
Trial: 25044219
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral 600 mg dose of linezolid (LZD)
Trial: 25044219
Drug: Linezolid (LZD)
RxNorm normalized name: Linezolid
DrugBank: Linezolid (DB00601)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Linezolid (LZD) administration timing
Trial: 22950484
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine 1 μg.kg(‐1) (Group 1)
Trial: 22950484
Drug: Intranasal dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dexmedetomidine 2 μg.kg(‐1) (Group 2)
Trial: 8981710
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy with TPA
Trial: 1985608
Drug: Lovastatin 80
RxNorm normalized name: fluvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 80 mg daily
Trial: 1985608
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg daily
Trial: 1985608
Drug: Lovastatin 40
RxNorm normalized name: lovastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 40 mg daily
Trial: 30773934
Drug: Intravitreal dexamethasone
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal dexamethasone implant (Ozurdex®)
Trial: 23375114
Drug: Recovery Line
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery Line plus Treatment-as-Usual (TAU)
Trial: 21107305
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g mycophenolate mofetil (group A, n=75)
Trial: 21107305
Drug: 1.440 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.440 g enteric-coated mycophenolate sodium (group B, n=75)
Trial: 19008470
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid treatment for 6 weeks
Trial: 19008470
Drug: Folic acid,
RxNorm normalized name: folic acid, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folic acid, vitamin B(12), and vitamin B(6) treatment for 3 months
Trial: 16182104
Drug: Regular red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular red wine (250 mL)
Trial: 16182104
Drug: Dealcoholized red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dealcoholized red wine (250 mL)
Trial: 10674881
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg and Megestrol acetate
Trial: 6345893
Drug: Dialyzer clearance
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialyzer clearance of urea (Kd, ml/min)
Trial: 6345893
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake monitoring (PCR, g/day)
Trial: 27668943
Drug: Full-dose (FD)
RxNorm normalized name: Rho(D) immune globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose (FD) anticonvulsants
Trial: 27668943
Drug: Half-dose (HD)
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose (HD) anticonvulsants
Trial: 27668943
Drug: Stop anticonvulsants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop anticonvulsants
Trial: 27098525
Drug: Insulin Glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin Glargine (IGlar)
Trial: 23346907
Drug: Calcium hydroxide
RxNorm normalized name: Calcium Hydroxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium hydroxide indirect pulp treatment (CH‐IPT)
Trial: 23346907
Drug: Antibiotic sterilization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic sterilization using a mixture of three antibiotics (3Mix‐MP)
Trial: 23938229
Drug: Deep brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep brain stimulation plus optimal drug therapy
Trial: 18775043
Drug: Drug challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug challenge ECGs (group B)
Trial: 12067328
Drug: Interferon-beta 1a
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-beta 1a (6 MIU once weekly i.m.)
Trial: 9498655
Drug: Trandolapril 0.5
RxNorm normalized name: trandolapril 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril 0.5 mg day(-1) (L)
Trial: 2677240
Drug: Brofaromine 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine 150 mg/day
Trial: 31847
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy and imipramine hydrochloride
Trial: 1002948
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy and placebo
Trial: 31847
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment regimens (including imipramine and placebo) in simple phobic patients
Trial: 31484021
Drug: Lifestyle Redesign®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle Redesign® occupational therapy (LR-OT)
Trial: 23898894
Drug: Liberal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal treatment group received one unit of packed red blood cells and as much blood as needed to maintain hemoglobin concentrations at greater than 10 g/dL; median two units of blood received.
Trial: 23898894
Drug: Restrictive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive treatment group received transfusions if they developed symptoms of anemia or their hemoglobin fell below 8 g/dL; median zero units of blood received.
Trial: 21704240
Drug: Dalcetrapib 900
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 900 mg in fed state
Trial: 21704240
Drug: Dalcetrapib 600
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 600 mg after light morning meal
Trial: 21704240
Drug: Dalcetrapib 600
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 600 mg after light evening meal
Trial: 21704240
Drug: Dalcetrapib 600
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 600 mg after standard evening meal
Trial: 21704240
Drug: Dalcetrapib 600
RxNorm normalized name: Dalcetrapib
DrugBank: Dalcetrapib (DB12181)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib 600 mg after high-fat evening meal
Trial: 16319918
Drug: Paroxetine 10
RxNorm normalized name: PARoxetine 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 10 mg/day for 2 weeks, then 20 mg/day for 2 weeks, then 30 mg/day for 2 weeks
Trial: 16319918
Drug: Paroxetine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (various doses)
Trial: 10459684
Drug: 0.125 mg
RxNorm normalized name: digoxin 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg of triazolam (TRZ)
Trial: 7608255
Drug: Metformin administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin administration (850 mg, twice daily for 4 months)
Trial: 358763
Drug: Bendroflumethiazide (BFT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide (BFT), 10 mg, given orally after fasting overnight
Trial: 358763
Drug: Bendroflumethiazide (BFT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendroflumethiazide (BFT), 10 mg, given orally together with a meal
Trial: 18802184
Drug: Standard drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard drug counseling
Trial: 18802184
Drug: Motivational interviewing/skills-building
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motivational interviewing/skills-building therapy
Trial: 16007412
Drug: S21403 (mitiglinide)
RxNorm normalized name: mitiglinide
DrugBank: Mitiglinide (DB01252)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: S21403 (mitiglinide) 40 mg
Trial: 12407036
Drug: Fixed multiple
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed multiple dose antagonist protocol starting on day 6 of stimulation (group 1)
Trial: 12407036
Drug: Individualized protocol
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized protocol with the time of antagonist start according to follicle size (14 mm, group 2)
Trial: 12407036
Drug: Individualized single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized single dose protocol (group 3)
Trial: 9802369
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (200 microg twice daily)
Trial: 7618619
Drug: Captopril (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (150 mg/day in 3 separate doses)
Trial: 414272
Drug: Alcohol state
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol state (1.0 ml/kg)
Trial: 31601250
Drug: Social group/provider
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social group/provider intervention (social group treatment plus training of healthcare providers in health communication about MRDT)
Trial: 31601250
Drug: Control (usual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (usual practice of provision of MRDT services by public primary healthcare providers and patent medicine vendors)
Trial: 25491347
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg zinc as zinc sulfate daily for 17 days
Trial: 23663094
Drug: Licorice (1140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Licorice (1140 mg/day)
Trial: 23663094
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) - conjugated estrogen 0.312 mg/day and Medroxyprogesterone 2.5 mg/day
Trial: 17918451
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine for liver protection
Trial: 7928829
Drug: Nitrofurantoin modified
RxNorm normalized name: Nitrofurantoin
DrugBank: Nitrofurantoin (DB00698)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin modified release (MR) 100 mg bd
Trial: 7928829
Drug: Co-trimoxazole 960
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole 960 mg bd
Trial: 7928829
Drug: Trimethoprim 200
RxNorm normalized name: trimethoprim 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim 200 mg bd
Trial: 27668546
Drug: Oxycodone DETERx
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone DETERx (Xtampza ER) administered sprinkled onto soft foods or via enteral feeding tubes
Trial: 27668546
Drug: Oxycodone DETERx
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone DETERx (Xtampza ER)
Trial: 23746376
Drug: eGFR ≤29
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR ≤29 mL/min/1.73 m²
Trial: 10644899
Drug: Estradiol patches
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Estradiol patches (Estraderm TTS; 0.8 mg)
Trial: 10644899
Drug: d-amphetamine (AMPH;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (AMPH; 10 mg p.o.)
Trial: 30185583
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (HFNC) oxygen therapy alone
Trial: 30185583
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula (HFNC) oxygen therapy with non-invasive ventilation (NIV) sessions
Trial: 26655425
Drug: Bendamustine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine plus rituximab (90 mg/m2 on days 1 and 2, rituximab 375 mg/m2 on day 1)
Trial: 26655425
Drug: Fludarabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludarabine plus rituximab (25 mg/m2 on days 1-3, rituximab 375 mg/m2 on day 1)
Trial: 25001947
Drug: sublingual melatonin
RxNorm normalized name: Melatonin/Pyridoxine 2.5 MG-0.338 MG Sublingual Tablet [BASIC'S SUBLINGUAL MELATONIN WITH B6]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual melatonin 3 mg
Trial: 25001947
Drug: sublingual melatonin
RxNorm normalized name: Melatonin/Pyridoxine 2.5 MG-0.338 MG Sublingual Tablet [BASIC'S SUBLINGUAL MELATONIN WITH B6]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual melatonin 10 mg
Trial: 25001947
Drug: sublingual placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual placebo
Trial: 20375422
Drug: 0.2 g
RxNorm normalized name: methionine 0.2 gram ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 g of fish oil emulsion/kg infusion for 14 days
Trial: 20375422
Drug: 0.05 g
RxNorm normalized name: TRETINOIN 0.05 g in 100 g TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05 g of fish oil/kg oral capsules after infusion
Trial: 20375422
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline infusion (placebo) for 14 days
Trial: 20375422
Drug: Paraffin wax
RxNorm normalized name: Paraffin Wax
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paraffin wax oral capsules (placebo) after infusion
Trial: 18415808
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (800 microg daily, 6 months)
Trial: 18415808
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (30 mg daily, 3 weeks)
Trial: 10411559
Drug: Omeprazole (i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (i.v. administration in therapeutic doses)
Trial: 7480549
Drug: Adinazolam 15
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam 15 mg
Trial: 7480549
Drug: Adinazolam 45
RxNorm normalized name: adinazolam
DrugBank: Adinazolam (DB00546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adinazolam 45 mg
Trial: 7480549
Drug: Alprazolam (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (high dose) vs Adinazolam (high dose)
Trial: 7006345
Drug: Cinoxacin at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinoxacin at a dosage of 500 mg b.i.d.
Trial: 7006345
Drug: Nalidixic acid
RxNorm normalized name: Nalidixic Acid
DrugBank: Nalidixic acid (DB00779)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nalidixic acid at a dosage of 1 g q.i.d.
Trial: 26217089
Drug: Risk prediction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk prediction scoring model (based on age ≥ 40 years, total bilirubin ≥ 171 μmol/L, prothrombin activity 40%‐60%, hepatitis B virus DNA > 107 copies/mL)
Trial: 23001540
Drug: Resinous extract
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resinous extract from Commiphora swynnertonii at 400 mg/kg bodyweight
Trial: 23001540
Drug: Resinous extract
RxNorm normalized name: Benzoin resin
DrugBank: Benzoin resin (DB11222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resinous extract from Commiphora swynnertonii at 800 mg/kg bodyweight
Trial: 23001540
Drug: Anticoccidial drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoccidial drug
Trial: 21124045
Drug: Transtympanic steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transtympanic steroid injection (4 courses of methylprednisolone after conventional treatment)
Trial: 11439379
Drug: Conventional steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional steroid treatment
Trial: 11372906
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care services
Trial: 2890442
Drug: pancuronium 0.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pancuronium 0.12 mg.kg‐1
Trial: 2890442
Drug: vecuronium 0.12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vecuronium 0.12 mg.kg‐1
Trial: 2890442
Drug: atracurium 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atracurium 0.4 mg.kg‐1
Trial: 2890442
Drug: pancuronium‐metocurine mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pancuronium‐metocurine mixture (0.4 mg + 1.6 mg/ml): 1 ml/10 kg
Trial: 27581680
Drug: Pitavastatin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin (4 mg/day)
Trial: 21965490
Drug: Transmucosal herbal
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transmucosal herbal periodontal patch (THPP) for three days
Trial: 21965490
Drug: Placebo patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patches (PP) for three days